Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of atomoxetine in treating
Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms in children and adolescents with
ADHD and comorbid reading disability (dyslexia)